{
    "eid": "2-s2.0-85090106139",
    "title": "Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson\u2019s Disease: A Review",
    "cover-date": "2020-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemistry (miscellaneous)",
            "@code": "1601",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Physical and Theoretical Chemistry",
            "@code": "1606",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "Green tea",
        "Neurodegenerative diseases",
        "Neuroprotection",
        "Parkinson\u2019s disease",
        "Polyphenols"
    ],
    "authors": [
        "Dicson Sheeja Malar",
        "Mani Iyer Prasanth",
        "James Michael Brimson",
        "Rajasekharan Sharika",
        "Bhagavathi Sundaram Sivamaruthi",
        "Chaiyavat Chaiyasut",
        "Tewin Tencomnao"
    ],
    "citedby-count": 34,
    "ref-count": 150,
    "ref-list": [
        "Tea and health: A historical perspective",
        "Beneficial effects of green tea\u2014A review",
        "Green Tea\u2014Its cultivation, processing of the leaves for drinking materials and kinds of green tea",
        "A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy",
        "Dietary habits, lifestyle factors and neurodegenerative diseases",
        "Molecular diagnostics of neurodegenerative disorders",
        "An essay on the shaking palsy",
        "The clinical symptoms of Parkinson\u2019s disease",
        "Parkinson\u2019s disease symptoms: The patient\u2019s perspective",
        "Cognitive deficits in the early stages of Parkinson\u2019s disease",
        "Cognitive impairments associated with early Parkinson\u2019s disease",
        "Cognitive deficits in Parkinson\u2019s disease",
        "Cognitive function in Parkinson\u2019s disease: From description to theory",
        "Non-motor symptoms of Parkinson\u2019s disease: Dopaminergic pathophysiology and treatment",
        "Verbal fluency deficits in Parkinson\u2019s disease",
        "Deficit of verb generation in nondemented patients with Parkinson\u2019s disease",
        "Cognitive impairment in early, untreated Parkinson\u2019s disease and its relationship to motor disability",
        "Visuospatial impairment in Parkinson\u2019s disease",
        "Risk of dementia in Parkinson\u2019s disease. A community-based prospective study",
        "Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016",
        "Epidemiology of Parkinson\u2019s disease",
        "Epidemiology of Parkinson\u2019s disease",
        "Prevalence of Parkinson\u2019s disease in the elderly: The Rotterdam Study",
        "Young onset Parkinson\u2019s disease",
        "Are men at greater risk for Parkinson\u2019s disease than women?",
        "Head injury and risk of Parkinson disease: A systematic review and meta-analysis",
        "Risk factors for Parkinson\u2019s disease",
        "A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease",
        "Synuclein, dopamine and oxidative stress: Co-conspirators in Parkinson\u2019s disease?",
        "Overview of Parkinson\u2019s disease",
        "Overview of Parkinson\u2019s disease",
        "Etiology and pathogenesis of Parkinson disease",
        "\u03b1-Synuclein in Parkinson\u2019s disease",
        "Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy",
        "Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity",
        "Polycation-induced oligomerization and accelerated fibrillation of human \u03b1-synuclein in vitro",
        "\u03b1-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity",
        "Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain",
        "Mitochondrial complex I deficiency in Parkinson\u2019s disease",
        "Parkinson\u2019s disease \u03b1-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death",
        "Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity",
        "Parkinson\u2019s disease: Mechanisms and models",
        "Parkinson\u2019s disease: Summary of updated NICE guidance",
        "Anti-inflammatory drugs and Alzheimer disease",
        "Emerging drugs for Parkinson\u2019s disease",
        "Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration",
        "Definition of a molecular pathway mediating alpha-synuclein neurotoxicity",
        "Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease",
        "Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease",
        "EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers",
        "Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson\u2019s Disease",
        "(-)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity",
        "EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity",
        "How epigallocatechin gallate can inhibit \u03b1-synuclein oligomer toxicity in vitro",
        "Neuroimaging in pre-motor Parkinson\u2019s disease",
        "Pathophysiology of Motor Dysfunction in Parkinson\u2019s Disease as the Rationale for Drug Treatment and Rehabilitation",
        "In vivo, in vitro and pharmacologic models of Parkinson\u2019s disease",
        "Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral \u03b1-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys",
        "Green tea polyphenol (-)-epigallocatechin-3gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration",
        "Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: Effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate",
        "Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: Implications for neuroprotection",
        "How protein kinase C activation protects nerve cells from oxidative stress-induced cell death",
        "Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury",
        "Dopamine Reuptake Inhibitors in Parkinson\u2019s Disease: A Review of Nonhuman Primate Studies and Clinical Trials",
        "(-)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway",
        "Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: In vitro and in vivo studies",
        "Monoamine oxidase inactivation: From pathophysiology to therapeutics",
        "Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders",
        "Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains",
        "Iron and neurodegeneration: From cellular homeostasis to disease",
        "Metal chelator EGCG attenuates Fe(III)-induced conformational transition of \u03b1-synuclein and protects AS-PC12 cells against Fe(III)-induced death",
        "EGCG inhibit chemical reactivity of iron through forming anNgal-EGCG-iron complex",
        "Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease",
        "Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism",
        "Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options",
        "Natural ways to prevent and treat oral cancer",
        "Green Tea Consumption Reduces Oxidative Stress in Parkinson\u2019s Disease Patients",
        "Effect of epicatechingallate dietary supplementation on transgenic Drosophila model of Parkinson\u2019s disease",
        "Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders",
        "Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease",
        "4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death",
        "Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation",
        "The effect of green tea in oxidative stress",
        "L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes",
        "Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice",
        "Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis",
        "Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line",
        "Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons",
        "Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson\u2019s disease through inhibition of ROS-NO pathway",
        "Protein nitration in Parkinson\u2019s disease",
        "Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies",
        "Functional consequences of alpha-synuclein tyrosine nitration: Diminished binding to lipid vesicles and increased fibril formation",
        "Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-\u03b2 Drosophila melanogaster",
        "Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson\u2019s disease",
        "\u03b1-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions",
        "\u03b1-Synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease",
        "Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway",
        "Reduction in Autophagy by (-)-Epigallocatechin-3-Gallate (EGCG): A Potential Mechanism of Prevention of Mitochondrial Dysfunction After Subarachnoid Hemorrhage",
        "PGC-1\u03b1, Inflammation, and Oxidative Stress: An Integrative View in Metabolism",
        "Regulation of mitochondrial biogenesis",
        "SIRT1/PGC-1\u03b1 Signaling Promotes Mitochondrial Functional Recovery and Reduces Apoptosis after Intracerebral Hemorrhage in Rats",
        "Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1\u03b1 signaling pathway",
        "Global PD Gene Expression (GPEX) Consortium. PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease",
        "Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade",
        "Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death",
        "Neural heme oxygenase-1 expression in idiopathic Parkinson\u2019s disease",
        "MAPK signaling in neurodegeneration: Influences of flavonoids and of nitric oxide",
        "Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress",
        "Requirement of ERK activation for visual cortical plasticity",
        "Mory\u00b4 s, J. BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity",
        "TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease",
        "Brain-derived neurotrophic factor in neurodegenerative diseases",
        "Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTORsignalling pathways in neonatal mice",
        "Functional roles of CREB as a positive regulator in the formation and enhancement of memory",
        "Akt signal transduction dysfunction in Parkinson\u2019s disease",
        "A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine",
        "Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism",
        "(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson\u2019s disease",
        "Protective Effect of (-)-Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats",
        "Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatonin",
        "Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia",
        "Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons",
        "Neuroprotective Activity of (-)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity",
        "Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson\u2019s Disease",
        "Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease",
        "Involvement of nitric oxide in neurodegeneration: A study on the experimental models of Parkinson\u2019s disease",
        "Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease in mice by tea phenolic epigallocatechin 3-gallate",
        "Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease",
        "Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson\u2019s disease induced by L-DOPA?",
        "Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors",
        "Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson\u2019s disease",
        "Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration",
        "The potential role of neuroinflammation and transcription factors in Parkinson disease",
        "Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures",
        "The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder",
        "Oral and nasal microbiota in Parkinson\u2019s disease",
        "Colonic bacterial composition in Parkinson\u2019s disease",
        "EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson\u2019s disease",
        "Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation",
        "A comparison of the antimutagenic potential of green, black and decaffeinated teas: Contribution of flavanols to the antimutagenic effect",
        "Genotoxicity studies on green tea catechin",
        "28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats",
        "Fourteen-week toxicity study of green tea extract in rats and mice",
        "The safety of green tea and green tea extract consumption in adults\u2014Results of a systematic review",
        "Oxidative Stress: A Key Modulator in Neurodegenerative Diseases",
        "Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and its Metabolites",
        "Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice",
        "Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?",
        "Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications",
        "Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Second Century Fund",
        "Chiang Mai University",
        "Chulalongkorn University"
    ]
}